BR
Bradway Robert A Director General
C-suite M
Historial del iniciado Director General Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Explore the full record of transactions filed by Bradway Robert A, Director General. Officer active across 1 company, notably AMGEN INC. Cumulatively, 33 reports have been logged. History available since 30 April 2021. The latest transaction was filed on 2 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bradway Robert A Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones 33 en total
● Chairman, CEO and President · Directivos · 2 may 2026 · AMGEN INC 2631 títulos @ 329,82 US$ 0.0004% mcap 3.3% de su flujo Common Stock SEC:0000318154-26-000058:0
● Chairman, CEO and President · Directivos · 2 may 2026 · AMGEN INC 2426 títulos @ 329,82 US$ 0.0004% mcap 3.0% de su flujo Common Stock SEC:0000318154-26-000058:1
● Chairman, CEO and President · Directivos · 16 mar 2026 · AMGEN INC 21.294 títulos @ 366,21 US$ 23.1% de su flujo Common Stock SEC:0000318154-26-000025:0
◇ Chairman, CEO and President · Directivos · 4 mar 2026 · AMGEN INC 119.782 títulos @ 156,35 US$ 35.4% de su flujo Common Stock SEC:0000318154-26-000023:0
◆ Chairman, CEO and President · Directivos · 3 mar 2026 · AMGEN INC 42.657 títulos 0Common Stock SEC:0000318154-26-000014:0
◆ Chairman, CEO and President · Directivos · 6 may 2025 · AMGEN INC 13.311 títulos 0Common Stock SEC:0001127602-25-013788:0
● Chairman, CEO and President · Directivos · 2 may 2025 · AMGEN INC 2352 títulos @ 283,78 US$ 2.6% de su flujo Common Stock SEC:0001127602-25-013525:1
● Chairman, CEO and President · Directivos · 2 may 2025 · AMGEN INC 2481 títulos @ 283,78 US$ 2.7% de su flujo Common Stock SEC:0001127602-25-013525:0
● Chairman, CEO and President · Directivos · 30 abr 2025 · AMGEN INC 2544 títulos @ 288,56 US$ 2.9% de su flujo Common Stock SEC:0001127602-25-013278:0
● Chairman, CEO and President · Directivos · 17 mar 2025 · AMGEN INC 12.853 títulos @ 313,71 US$ 16.3% de su flujo Common Stock SEC:0001127602-25-010053:0
◆ Chairman, CEO and President · Directivos · 3 mar 2025 · AMGEN INC 25.734 títulos 0Common Stock SEC:0001127602-25-008420:0
● Chairman, CEO and President · Directivos · 2 dic 2024 · AMGEN INC 96.000 títulos 0Common Stock SEC:0001127602-24-028560:0
● Chairman, CEO and President · Directivos · 2 dic 2024 · AMGEN INC 90.000 títulos 0Common Stock SEC:0001127602-24-028560:1
● Chairman, CEO and President · Directivos · 2 dic 2024 · AMGEN INC 90.000 títulos 0Common Stock SEC:0001127602-24-028560:2
◆ Chairman, CEO and President · Directivos · 7 may 2024 · AMGEN INC 11.988 títulos 0Common Stock SEC:0001127602-24-014847:0
● Chairman, CEO and President · Directivos · 5 may 2024 · AMGEN INC 2220 títulos @ 311,29 US$ 2.8% de su flujo Common Stock SEC:0001127602-24-014504:0
● Chairman, CEO and President · Directivos · 2 may 2024 · AMGEN INC 2294 títulos @ 277,37 US$ 2.6% de su flujo Common Stock SEC:0001127602-24-014350:0
● Chairman, CEO and President · Directivos · 30 abr 2024 · AMGEN INC 2282 títulos @ 276,38 US$ 2.6% de su flujo Common Stock SEC:0001127602-24-013809:0
● Chairman, CEO and President · Directivos · 18 mar 2024 · AMGEN INC 20.560 títulos @ 268,87 US$ 22.4% de su flujo Common Stock SEC:0001127602-24-010846:0
◆ Chairman, CEO and President · Directivos · 6 mar 2024 · AMGEN INC 41.133 títulos 0Common Stock SEC:0001127602-24-009236:0
● Chairman, CEO and President · Directivos · 5 may 2023 · AMGEN INC 2083 títulos @ 231,89 US$ 1.9% de su flujo Common Stock SEC:0001127602-23-015043:0
◆ Chairman, CEO and President · Directivos · 2 may 2023 · AMGEN INC 13.486 títulos 0Common Stock SEC:0001127602-23-014605:0
● Chairman, CEO and President · Directivos · 30 abr 2023 · AMGEN INC 2208 títulos @ 239,74 US$ 2.1% de su flujo Common Stock SEC:0001127602-23-014149:0
● Chairman, CEO and President · Directivos · 17 mar 2023 · AMGEN INC 13.971 títulos @ 234,57 US$ 13.6% de su flujo Common Stock SEC:0001127602-23-010906:0
◆ Chairman, CEO and President · Directivos · 6 mar 2023 · AMGEN INC 27.915 títulos 0Common Stock SEC:0001127602-23-009505:0
25 de 33 declaraciones
Ver más (8 restantes) About Bradway Robert A Bradway Robert A is Chairman, CEO and President at AMGEN INC. He has 33 filings in total, and among the sampled recent filings the most common transaction nature is tax withholding, with buy and sell amounts of EUR 0 over the period from 2016-02-01 to 2026-05-05.